Biotech

All Articles

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has made a late entry to the radioligand event, paying out one hundred million euros ($ 110 ...

F 2G rears $100M for 2nd try to receive brand-new antifungal to market

.After F2G's very first effort to receive a brand-new class of antifungal to market was hindered by ...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 systems among profitability tensions

.Moderna has actually sworn to reduce R&ampD costs by $1.1 billion through 2027. The selection to sh...

Sanofi's $80M bank on Key dystrophy drug finishes in phase 3 go under

.Merely 4 months after Sanofi wager $80 thousand in beforehand money on Key Therapeutics' losmapimod...

Oncternal stock drains 60% amidst layoffs, test firings

.Cancer cells provider Oncternal Rehabs is actually folding all its own scientific tests and giving ...

Roche is actually keeping out hopes that its own injectable excessive weight prospect might ultimately show 25% effective weight loss in late-stage test

.Roche is actually keeping out hopes that its own injectable being overweight prospect could eventua...

Novo Nordisk hails 'outstanding' weight-loss result for dual-acting oral drug in very early trial

.Novo Nordisk has actually lifted the top on a period 1 trial of its own oral amylin and also GLP-1 ...

AbbVie sues BeiGene over blood stream cancer cells drug secret method

.Only a few short weeks after succeeding an FDA Fast Track tag for its own investigational BTK degra...

Lilly provides one-two hit along with 2nd tranche of beneficial data on every week blood insulin candidate

.Not long after a favorable records drop for Eli Lilly's efsitora alfa, the Indianapolis-based provi...

BridgeBio reduces gene therapy budget as clinical information disappoint

.BridgeBio Pharma is lowering its genetics treatment spending plan and also drawing back coming from...